Trianect BV

Trianect BV is an Academic Medical Center (AMC) and Neuromotion ventures spin-off of Wouter Potters, Jonathan Coutinho and Henk Marquering. Trianect’s mission is to reduce unnecessary delays in theĀ endovascular treatment of patients with stroke, resulting in a faster and better recovery with great economic benefit. To achieve this, Trianect develops a medical device that can perform pre-hospital stroke triage by analyzing brain signals with AI algorithms, enabling ambulance personnel to bring each suspected stroke patient directly to the right hospital for the right treatment.

Trianect BV

Utrecht

info@trianect.com